Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Gibb

Showing results (151-160 of 327) with videos related to

Pageof 33
Sort By:
Clinical and Experimental Dermatology|January 24, 2017
Myaesthenia gravis exacerbation caused by axillary injection of botulinum toxin A for treatment of hyperhidrosisS El-Heis, G Burke, W Gibb, et al.
Neuropharmacology|December 1, 1981
Long-term effects of methamphetamine on the synthesis and metabolism of 5-hydroxytryptamine in various regions of the rat brainC Bakhit, M E Morgan, M A Peat, et al.
NIDA Research Monograph|January 1, 1993
Mechanisms mediating biogenic amine deficits induced by amphetamine and its congenersJ W Gibb, M Johnson, D M Stone, et al.
The Journal of Endocrinology|April 6, 2000
Localization of prostaglandin synthase type-1 (PGHS-1) mRNA and prostaglandin synthase type-2 (PGHS-2) mRNA in ovine myometrium and endometrium throughout gestationW Gibb, M Sun, S Gyomorey, et al.
Biochemical Pharmacology|September 15, 1988
Effects of methamphetamine on central monoaminergic systems in normal and ascorbic acid-deficient guinea pigsL A Matsuda, C J Schmidt, J W Gibb, et al.
Drug and Alcohol Dependence|February 1, 1995
The role of NMDA receptor systems in neuropeptide responses to stimulants of abuseG R Hanson, N Singh, K Merchant, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1984
Increases of substance P-like immunoreactivity within striatal-nigral structures after subacute methamphetamine treatmentJ K Ritter, C J Schmidt, J W Gibb, et al.
European Journal of Pharmacology|September 9, 1986
Response of mesolimbic substance P systems to methamphetamine treatmentG R Hanson, J K Ritter, C J Schmidt, et al.
Brain Research|December 5, 1994
Endogenous neurotensin antagonizes methamphetamine-enhanced dopaminergic activityJ D Wagstaff, L G Bush, J W Gibb, et al.
European Journal of Pharmacology|August 22, 1986
The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brainD M Stone, D C Stahl, G R Hanson, et al.
Pageof 33

Showing results (151-160 of 327) with videos related to

Sort By:
Pageof 33
Clinical and Experimental Dermatology|January 24, 2017
Myaesthenia gravis exacerbation caused by axillary injection of botulinum toxin A for treatment of hyperhidrosisS El-Heis, G Burke, W Gibb, et al.
Neuropharmacology|December 1, 1981
Long-term effects of methamphetamine on the synthesis and metabolism of 5-hydroxytryptamine in various regions of the rat brainC Bakhit, M E Morgan, M A Peat, et al.
NIDA Research Monograph|January 1, 1993
Mechanisms mediating biogenic amine deficits induced by amphetamine and its congenersJ W Gibb, M Johnson, D M Stone, et al.
The Journal of Endocrinology|April 6, 2000
Localization of prostaglandin synthase type-1 (PGHS-1) mRNA and prostaglandin synthase type-2 (PGHS-2) mRNA in ovine myometrium and endometrium throughout gestationW Gibb, M Sun, S Gyomorey, et al.
Biochemical Pharmacology|September 15, 1988
Effects of methamphetamine on central monoaminergic systems in normal and ascorbic acid-deficient guinea pigsL A Matsuda, C J Schmidt, J W Gibb, et al.
Drug and Alcohol Dependence|February 1, 1995
The role of NMDA receptor systems in neuropeptide responses to stimulants of abuseG R Hanson, N Singh, K Merchant, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1984
Increases of substance P-like immunoreactivity within striatal-nigral structures after subacute methamphetamine treatmentJ K Ritter, C J Schmidt, J W Gibb, et al.
European Journal of Pharmacology|September 9, 1986
Response of mesolimbic substance P systems to methamphetamine treatmentG R Hanson, J K Ritter, C J Schmidt, et al.
Brain Research|December 5, 1994
Endogenous neurotensin antagonizes methamphetamine-enhanced dopaminergic activityJ D Wagstaff, L G Bush, J W Gibb, et al.
European Journal of Pharmacology|August 22, 1986
The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brainD M Stone, D C Stahl, G R Hanson, et al.
Pageof 33